Ocrelizumab use in the real-world experience: data from a hot spot area for Multiple Sclerosis

被引：0

作者：

Mellino, P. ^{[1
]}

Lorefice, L. ^{[1
]}

Pilotto, S. ^{[1
]}

Frau, J. ^{[1
]}

Pintus, M. ^{[1
]}

Barca, S. ^{[1
]}

Coghe, G. ^{[1
]}

Barracciu, M. ^{[2
]}

Cocco, E. ^{[1
]}

机构：

[1] Univ Cagliari, Multiple Sclerosis Ctr, Dept Med Sci & Publ Hlth, ASL Cagliari,Binaghi Hosp, Cagliari, Italy

[2] ASL Cagliari, Binaghi Hosp, Radiol Unit, Cagliari, Italy

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPO-497

引用

页码：634 / 635

页数：2

共 50 条

[31] Real-world Experience with Ocrelizumab - A Safety Analysis
Bolling, Jamie
Vasquez, Matthew
Sollero, Carlos Eduardo Vervloet
Carlson, Aaron
Gyang, Tirisham
[J]. NEUROLOGY, 2020, 94 (15)
[32] Real-world experience with ocrelizumab in the msbase registry
Butzkueven, H.
Spelman, T.
Ozakbas, S.
Kalincik, T.
Boz, C.
Buzzard, K.
Skibina, O.
Alroughani, R.
Karabudak, R.
Van der Walt, A.
Lechner-Scott, J.
Hodgkinson, S.
Laureys, G.
Van Hijfte, L.
Terzi, M.
Butler, E.
Macdonell, R.
Patti, F.
Van Pesch, V.
Slee, M.
Barnett, M.
Grammond, P.
Prevost, J.
Grand-Maison, F.
Taylor, B.
Kermode, A.
Mccombe, P.
Duquette, P.
Prat, A.
Girard, M.
Eichau Madueno, S.
Izquierdo, G.
Soysal, A.
Sanchez-Menoyo, J. L.
Sotoca, J.
Muros-Le Rouzic, E.
Dirks, P.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 550 - 551
[33] ACAPELLA: Real-World Experience with Ocrelizumab, 6-Year Data
Douglas, Elizabeth
O'Shea, Isabella
Greenawalt, Paige
Bouley, Andrew
Lathi, Ellen
Katz, Joshua
[J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 979 - 980
[34] Ocrelizumab in people with primary progressive multiple sclerosis: A real-world multicentric study
Skoric, Magdalena Krbot
Kes, Vanja Basic
Grbic, Nevena
Lazibat, Ines
Pavelin, Sanda
Zubonja, Tea Mirosevic
Komso, Milica
Piskac, Spomenka Kidemet
Abicic, Ana
Piskac, Dominik
Adamec, Ivan
Barun, Barbara
Gabelic, Tereza
Habek, Mario
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 89
[35] Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data
Gitman, Victor
Stavropoulos, Aphrodite
Saenz, Victoria
Pasquarelli, Noemi
Zecevic, Dusanka
Devonshire, Virginia
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 62
[36] Real world experience with ocrelizumab in patiens with relapsing-remitting multiple sclerosis
Lopez Ruiz, R.
Dotor Garcia-Soto, J.
Hiraldo, J. D. G.
Ruiz-Pena, J. L.
Paramo Camino, M. D.
Ruiz De Arcos, M.
Navarro Mascarell, G.
Eichau Madueno, S.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 301 - 301
[37] Ocrelizumab treatment in patients with relapsing-remitting multiple sclerosis: a single-center real-world experience
Lapucci, C.
Boffa, G.
Cellerino, M.
Novi, G.
Sbragia, E.
Bruschi, N.
Mancuso, E.
Tazza, F.
Laroni, A.
Capello, E.
Uccelli, A.
Inglese, M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 177 - 178
[38] A real-world data study of coronavirus-2019 disease severity in patients with multiple sclerosis treated with ocrelizumab
Dillon, P.
Waqar, A.
Roumpanis, S.
Martinec, M.
Muros-Le Rouzic, E.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 103 - 104
[39] Real-world experience with ocrelizumab in the german neurotransdata registry
Braune, S.
Heer, Y.
Tozzi, V.
Van Hoevell, P.
Muros-Le Rouzic, E.
Dirks, P.
Bergmann, A.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 69 - 70
[40] Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience
Nasello, Martina
Zancan, Valeria
Rinaldi, Virginia
Marrone, Antonio
Renie, Roberta
Diamant, Selene
Marconi, Martina
Le Mura, Lorenzo
Salvetti, Marco
Buscarinu, Maria Chiara
Bellucci, Gianmarco
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)

← 1 2 3 4 5 →